Novavax (NASDAQ:NVAX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Novavax their estimated earnings by 10.23%, reporting an EPS of $-4.31 versus an estimate of $-3.91, which surprised analysts.
Revenue was up $21,820,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.12, which was followed by a 19.61% drop in the share price the next day.
Here’s a look at Novavax’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -3.63 | -3.60 | -1.49 | 1.73 |
| EPS Actual | -4.75 | -3.05 | -2.70 | -3.21 |
| Revenue Estimate | 387.87M | 233.90M | 304.88M | 230.56M |
| Revenue Actual | 298.02M | 447.23M | 276.66M | 157.02M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
